RSPH ETF: What Is It? A Complete Guide to Returns, Expense Ratio, Holdings, and Alternative ETFs
The Invesco S&P 500 Equal Weight Health Care ETF is a passive product that invests in the health care sector on an equal-weighted basis, offering balanced sector diversification. Sector concentration, fees, and the industry outlook are the key points to check, and comparison with market-cap-weighted health care ETFs is the main selection criterion. The trading ticker is RSPH.
What Is the Invesco S&P 500 Equal Weight Health Care ETF?
This is a passive sector ETF that tracks an index of S&P 500 health care sector stocks, weighted equally. It spreads investments with similar weightings across pharmaceuticals, biotech, medical devices, and health care services.
It suits sector investors who want exposure to health care while reducing concentration in large-cap names and keeping diversification balanced.
It is an ETF managed by Invesco using a passive (index-tracking) approach.
How Does the Invesco S&P 500 Equal Weight Health Care ETF Invest?
| Item | Details |
|---|---|
| Tracked Index | S&P 500 Equal Weight Health Care Index |
| Management Style | Passive (equal weight) |
| Rebalancing Frequency | Quarterly |
| Dividend Frequency | Quarterly |
| Expense Ratio | 0.40% |
The fund holds S&P 500 health care sector stocks at equal weights and rebalances them every quarter. Unlike market-cap weighting, it is not skewed toward large pharmaceutical stocks. It assigns similar weights to pharmaceuticals, biotech, medical devices, and health care services, diversifying evenly across the sector.
- Equal-weighted diversification that reduces large-cap concentration
- Balanced exposure across health care sub-industries
Invesco S&P 500 Equal Weight Health Care ETF Size and Costs (AUM and Management Fee)
Assets under management (AUM) stand at $1.0B, and the expense ratio is 0.40% per year.
Unlike market-cap-weighted health care ETFs, it has a relatively larger allocation to small and mid-cap stocks, so performance may differ in periods led by large pharmaceutical stocks.
Invesco S&P 500 Equal Weight Health Care ETF Performance and Trends
The health care sector is defensive in nature, but it is also affected by policy, drug pricing, and new drug development trends. The equal-weighted structure lowers reliance on large pharmaceutical stocks and reflects biotech and medical device trends more evenly, but the small and mid-cap allocation means volatility can be somewhat higher than with market-cap weighting.
Capital tends to flow into equal-weighted health care ETFs when demand for defensive sectors or interest in balanced health care diversification rises, while in large-cap-led markets money sometimes shifts to market-cap-weighted ETFs.
Invesco S&P 500 Equal Weight Health Care ETF Pros and Cons
Its strength is balanced diversification across the health care sector, while sector concentration, small and mid-cap volatility, and policy risk are the drawbacks.
💪 Key Strengths
⚠️ Points of Caution
Invesco S&P 500 Equal Weight Health Care ETF Alternative ETFs and Related Products
XLV, VHT, and XBI shown in the table are market-cap-weighted health care or biotech ETFs, so their weighting methods differ. To expand health care exposure, you can also compare U.S. health care IYH, broad health care FHLC, and small-cap health care PSCH. These differ in weighting method, sub-industry composition, and fees, so it is best to choose according to your investment style.
| Ticker | Name | Price | Change | AUM | Total Expense Ratio | Dividend Yield | 1Y |
|---|---|---|---|---|---|---|---|
| State Street Health Care Select Sector SPDR ETF | $181.17 | -2.2% | $49.6B | 0.08% | 1.41% | +18.7% | |
| Vanguard Health Care ETF | $334.34 | -2.0% | $21.0B | 0.09% | 1.38% | +17.8% | |
| State Street SPDR S&P Biotech ETF | $145.04 | -0.2% | $9.7B | 0.35% | 0.38% | +25.9% | |
| iShares U.S. Healthcare ETF | $75.75 | -2.1% | $4.8B | 0.37% | 1.05% | +18.0% | |
| Fidelity MSCI Health Care Index ETF | $86.45 | -2.0% | $4.1B | 0.08% | 1.18% | +18.2% |
| Ticker | Name | Weight | Price | Change | Market Cap | P/E | Dividend Yield |
|---|---|---|---|---|---|---|---|
| TPG Inc | - | $46.47 | +0.3% | $17.9B | 53.5 | 5.08% | |
| CNC | Centene Corp | 0.03% | $67.45 | -7.0% | $33.4B | 23.1 | - |
| HUM | Humana Inc | 0.02% | $385.78 | -13.0% | $46.3B | 37.5 | 0.96% |
| UNH | Unitedhealth Group Inc | 0.02% | $349.91 | -10.2% | $313.5B | 20.0 | 2.57% |
| ELV | Elevance Health Inc | 0.02% | $400.84 | -7.6% | $86.6B | 17.1 | 1.71% |
| WST | West Pharmaceutical Services Inc | 0.02% | $404.02 | -2.4% | $28.1B | 45.3 | 0.22% |
| Bio-Techne Corp | 0.02% | $72.75 | +0.2% | $11.4B | 66.5 | 0.44% | |
| IQV | IQVIA Holdings Inc | 0.02% | $257.84 | +0.1% | $42.5B | 31.3 | - |
| Baxter International Inc | 0.02% | $26.16 | +1.6% | $13.5B | - | 0.15% |
Invesco S&P 500 Equal Weight Health Care ETF Investor Checkpoints
These are the points to review before investing in RSPH. As an equal-weighted health care ETF, it is important to check sector concentration, small and mid-cap volatility, policy risk, and the fee level in advance.
| Checkpoint | What to Check | Current Status |
|---|---|---|
| 💵 Expense Ratio | Check the fee of the equal-weighted ETF | Needs checking |
| 🩺 Sector Concentration | Check concentration in the single health care sector | Concentrated |
| 📉 Volatility | Check volatility from the small and mid-cap weighting | Somewhat high |
| 📜 Policy Risk | Check the impact of changes in drug pricing and regulatory policy | Sensitive |
Because the fund is concentrated in the single health care sector, performance depends on changes in drug pricing and regulatory policy, and its small and mid-cap weighting can make it more volatile than market-cap-weighted funds. The limits on diversification caused by sector concentration should also be considered.
This passive ETF suits sector investors who want exposure to health care while reducing large-cap concentration and keeping diversification balanced. If you want large-cap-centered exposure, a market-cap-weighted health care ETF may be the better choice, and if you want balanced diversification, RSPH can be the alternative.
Disclaimer: This content is for informational purposes only and does not constitute investment advice. All investment responsibility lies with the investor.
This article reflects information as of June 4, 2026.